Literature DB >> 8093049

Heparin selectively inhibits gene expression of matrix metalloproteinase transin in cultured mesangial cells.

M Kitamura1, N Maruyama, T Mitarai, R Nagasawa, T Yokoo, O Sakai.   

Abstract

The aim of this study is to examine the transcriptional regulation of matrix metalloproteinase transin in glomerular mesangial cells responding to inflammatory cytokines and heparin. Northern blot analysis revealed that IL-1 beta preferentially induced transin mRNA. The stimulatory effect was not specific to transin, and upregulation of procollagen alpha 1(IV), laminin B2 and tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNAs was also observed. After IL-1 stimulation, expression of the transin transcript increased progressively for up to 48 hours, differing from the limited induction of procollagen alpha 1(IV) or TIMP-1. When mesangial cells were stimulated by IL-1 beta in the presence of heparin, transin expression was markedly suppressed in a dose-dependent manner. The inhibitory effect of heparin was specific to transin, and induction of procollagen alpha 1(IV), laminin B2 or TIMP-1 by IL-1 beta was not affected. These findings revealed the selective counter regulation by IL-1 beta and heparin of the transin expression in mesangial cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8093049     DOI: 10.1006/bbrc.1994.2328

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Heparin increases prolactin and modifies the effects of fgf-2 upon prolactin accumulation in pituitary primary cultures.

Authors:  Carlos Spuch; Yolanda Diz-Chaves; Diego Pérez-Tilve; Federico Mallo
Journal:  Endocrine       Date:  2004-07       Impact factor: 3.633

2.  Unusual glycosaminoglycans from a deep sea hydrothermal bacterium improve fibrillar collagen structuring and fibroblast activities in engineered connective tissues.

Authors:  Karim Senni; Farida Gueniche; Sylvie Changotade; Dominique Septier; Corinne Sinquin; Jacqueline Ratiskol; Didier Lutomski; Gaston Godeau; Jean Guezennec; Sylvia Colliec-Jouault
Journal:  Mar Drugs       Date:  2013-04-23       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.